Christopher Bowden, M.D.
DirectoratBicara Therapeutics· In proxies 2024–2025
Christopher Bowden, M.D. sits on 4 public boards.
Experience
- Bicara TherapeuticsPublic company · 2 yr
- Director2024 – Present · 2 yrStock in role -58%
- Alaunos Therapeutics, Inc.Public company
- Director? – PresentNo stock prices for these years
- Miragen Therapeutics, Inc.Public company
- Director? – PresentNo stock prices for these years
- Viridian Therapeutics, Inc.Public company
- Director? – PresentNo stock prices for these years
- Ziopharm Oncology, Inc.Public company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?